Press release
Immunoassay Market Expected to Reach USD 50.95 Billion by 2034, Growing at a CAGR of 4.4%
Immunoassay Market
Market Introduction:
An immunoassay is a laboratory test that utilizes the specific binding between antibodies and antigens to detect and measure the presence or concentration of a target substance in a sample. This test is widely used in various fields like clinical diagnostics, research, and environmental monitoring. The process relies on the high specificity and affinity between an antibody and its corresponding antigen. The antibody, often labeled with a detectable marker (e.g., enzyme, radioactive isotope, fluorophore), is used to identify the presence and concentration of the antigen. The amount of signal produced is proportional to the amount of antigen present in the sample, allowing for quantification. Immunoassays are widely used in clinical diagnostics, research, and industrial settings. They are also used to study the immune response to a particular drug during its development.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/immunoassay-market/request-for-sample
Growth Drivers:
• The increasing prevalence of chronic diseases and the rising demand for advanced diagnostic technologies are driving the market growth.
• The rising prevalence of chronic diseases worldwide is driving the immunoassay market demand.
• The expanding healthcare infrastructure in emerging economies and the rising investments in healthcare are boosting market expansion.
• Rising focus on personalized medicine and the increasing need for therapeutic drug monitoring in oncology and cardiology are fueling the need for immunoassays.
Competitive Landscape Analysis:
The immunoassay market competitive environment features a combination of well-established firms and rising companies aiming to gain market share in an industry that is experiencing rapid growth. Some of the major key players include:
• Abbott
• BD
• Beckman Coulter, Inc.
• BIOMÉRIEUX
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• QuidelOrtho Corporation
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/immunoassay-market/request-for-discount-pricing
Immunoassay Industry Developments
• October 2024: Bio-Rad launched the EQAS Specialty Immunoassay program, which combines 13 analytes to improve clinical utility, reduce costs, and simplify proficiency testing.
• July 2024: Beckman Coulter unveiled the DxC 500i Analyzer, a compact, integrated solution for clinical chemistry and immunoassays, offering scalability, efficiency, user-friendly workflows, and Six Sigma performance.
• September 2023: Thermo Fisher received FDA clearance for the first automated Chromogranin A test, allowing labs to monitor tumor progression in patients with gastroenteropancreatic neuroendocrine tumors, thus enhancing patient management and treatment evaluation.
Segmental Analysis
• The segmentation of the immunoassay market is done based on technology, products, specimen, application, end users, and region.
• By product, the reagents & kits segment held the largest market share in 2024, attributed to the rising incidence of chronic and infectious diseases.
• The blood segment, based on specimen, experienced significant market expansion in 2024 due to its broad use as a sample in numerous end-user sectors like hospitals, clinics, and laboratories.
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/immunoassay-market
By Products Outlook (Revenue, USD Billion, 2021-2034)
• Reagents & Kits
o ELISA Reagents & Kits
o Rapid Test Reagents & Kits
o ELISPOT Reagents & Kits
o Western Blot Reagents & Kits
o Other Reagents & Kits
• Analyzers/Instruments
o Open Ended Systems
o Closed Ended Systems
• Software & Services
By Technology Outlook (Revenue, USD Billion, 2021-2034)
• Radioimmunoassay (RIA)
• Enzyme Immunoassays (EIA)
o Chemiluminescence Immunoassays (CLIA)
o Fluorescence Immunoassays (FIA)
• Rapid Tests
• Others
By Specimen Outlook (Revenue, USD Billion, 2021-2034)
• Blood
• Saliva
• Urine
• Others
By Application Outlook (Revenue, USD Billion, 2021-2034)
• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease Testing
• Autoimmune Diseases
• Others
By End Users Outlook (Revenue, USD Billion, 2021-2034)
• Hospitals
• Laboratories
• Others
Buy Now:
https://www.polarismarketresearch.com/buy/4037/0
Regional Overview:
• North America
o US
o Canada
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Malaysia
o South Korea
o Indonesia
o Australia
o Vietnam
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Israel
o South Africa
o Rest of Middle East & Africa
• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America
Browse More Research Reports:
Data Center Asset Management Market:
https://www.polarismarketresearch.com/industry-analysis/data-center-asset-management-market
Digital Map Market:
https://www.polarismarketresearch.com/industry-analysis/digital-map-market
Metaverse in Healthcare Market:
https://www.polarismarketresearch.com/industry-analysis/metaverse-in-healthcare-market
Synoptophore Market:
https://www.polarismarketresearch.com/industry-analysis/synoptophore-market
Hereditary Testing Market:
https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoassay Market Expected to Reach USD 50.95 Billion by 2034, Growing at a CAGR of 4.4% here
News-ID: 3998524 • Views: …
More Releases from Polaris Market Research & Consulting
Rare Disease Genetic Testing Market Projected to Reach USD 3,790.38 Million by 2 …
In 2024, the rare disease genetic testing market was valued at USD 1,106.88 million. Over the forecast period, it is anticipated to grow from USD 1,242.80 million in 2025 to USD 3,790.38 million by 2034 at a CAGR of 13.2%.
Market Details :
Rare disease genetic testing involves analyzing an individual's genetic material (DNA) to identify specific mutations or changes associated with a rare genetic disorder. This can help confirm or rule…
Bioinformatics Services Market Poised to Reach USD 16,297.10 million by 2034, Gr …
Bioinformatics Services Market
According to Polaris Market Research analysis, the global bioinformatics services market was valued at USD 3,816.17 million in 2024. It is projected to reach USD 16,297.10 million by 2034, exhibiting a compound annual growth rate (CAGR) of 15.7% from 2025-2034.
Market Overview
Bioinformatics services encompass a broad gamut of computational procedures, algorithms, and instruments that ease the analysis, handling, and translation of biological computer science. Bioinformatics plays an important part…
Cell Lysis & Disruption Market Projected to Reach USD 13.03 Billion by 2034, Gro …
The cell lysis & disruption market was estimated to be worth USD 5.75 billion in 2024. With a CAGR of 8.5% from 2025 to 2034, the market is expected to grow from USD 6.23 billion in 2025 to USD 13.03 billion by 2034.
A few of the main factors driving the growth of this market are:
• The growing need for cell-based research and biopharmaceutical manufacturing is propelling market growth.
• Increasing use…
Lactation Support Supplements Market to Sail to US$ 1,209.90 Million With a 6.5% …
The lactation support supplements market is expected to gain market growth during the forecast period of 2025-2034. Polaris Market Research analyzes the market to account for USD 1,209.90 million by 2034 and is expected to register a CAGR of 6.5% in the above-mentioned forecast period. The market was valued at USD 643.04 million in 2024.
Market Overview:
Many modern parents who wish to benefit from breastfeeding strive to produce sufficient breast milk…
More Releases for Immunoassay
Insights On Immunoassay Market Outlook - Ken Research
An immunoassay is a biochemical analysis that measures the existence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen. Immunoassays in scientific research are typically used in the study of biological systems by tracing different proteins, hormones, and antibodies. In industry, they are used to identify contaminants in food and water, and to monitor specific molecules used during…
Bahrain Immunoassay Analyzer Market
Transparent healthcare framework & strict procurement system enables the authorities in gaining the trust of the end-users leading to the growth of the medical devices industry in Bahrain: Ken Research
Heavy Government involvement in the industry: Bahrain has been maintaining a basic framework for a transparent, rules-based government procurement system. Bahrain hospitals and clinics, as well as developing specialist treatments, are continuously growing. This has improved the installation of BGA, POC…
Bahrain Immunoassay Analyzer Market: Ken Research
The report titled "Bahrain Blood Gas and POC Immunoassay AnalyzerMarket Outlook to 2026-Multiple programs to modernize the Bahraini healthcare sector in future including Health Insurance, Health centers and Primary Care Autonomy" provides a comprehensive analysis of the Diagnostic Equipments used in Hospitals and Independent Labs. Report also covers overview and genesis of the industry, product wise market size in terms of installed base; market segmentation by type of device, type…
Immunoassay Market Competitive Dynamics 2027
According to the new research report published by The Insight Partners, titled "Immunoassay Market- Global Analysis and Forecast to 2027".
The global immunoassay market is US$ 21,800.0 Mn in 2018 and is predicted to grow at a CAGR of 6.5% during the forecast period 2019 - 2027, to reach US$ 37,987.8 Mn by 2027.
Immunoassay Market Report presents a competitive scenario of key Immunoassay Industry players with their market share, sales, revenue…
Immunoassay Market: Opportunities and Challenges
The Immunoassay Market is expected to reach 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436
Will the development of condition-specific biomarkers and tests create opportunities for growth for players in the immunoassay market?
Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases.…
Immunoassay Growth Insights 2019 by Major Key Drivers like biotechnology and pha …
Immunoassay Market Highlights
Immunoassay is widely used in significant areas of pharmaceutical analysis which include diagnosis of diseases and in therapeutic drug monitoring.
A number of factors such as the increasing prevalence of chronic conditions, growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, rising use of immunoassay in oncology, growing awareness about immunoassay, healthcare insurance coverage for various infectious diseases, unmet medical needs, improving regulatory framework, and…
